DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $108,000 | -46.0% | 5,365 | 0.0% | 0.00% | -42.9% |
| Q2 2021 | $200,000 | +46.0% | 5,365 | 0.0% | 0.01% | +40.0% |
| Q1 2021 | $137,000 | +8.7% | 5,365 | -6.5% | 0.01% | -16.7% |
| Q4 2020 | $126,000 | +22.3% | 5,739 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $103,000 | -29.5% | 5,739 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $146,000 | +78.0% | 5,739 | +29.0% | 0.01% | +40.0% |
| Q1 2020 | $82,000 | -16.3% | 4,450 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $98,000 | +53.1% | 4,450 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $64,000 | -8.6% | 4,450 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $70,000 | +7.7% | 4,450 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $65,000 | +66.7% | 4,450 | +22.9% | 0.00% | +50.0% |
| Q4 2018 | $39,000 | -29.1% | 3,620 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $55,000 | +25.0% | 3,620 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $44,000 | – | 3,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |